# K083425: Fusion Advantage Cervical Cage, Fusion Advantage Lumbar Cage

- Pathway: 510(k) (Traditional)
- Applicant: Adaptive Specialty, LLC
- Decided: Mar 20, 2009 after 121 days
- Product code: ODP (Intervertebral Fusion Device With Bone Graft, Cervical)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
17 later devices descend from it; 2 cite it directly.
0 of 18 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K170297: Tranquil Interbody System (2017), 15 descendants of its own
- K181702: Tranquil-L Interbody System (2018), 8 descendants of its own
- K212498: Stable-L Standalone Lumbar Interbody System (2022), 7 descendants of its own
- K181621: Stable-C Interbody System (2018), 7 descendants of its own
- K231763: Stable-C Interbody System (2023), 6 descendants of its own

## Indications for use
Fusion Advantage Cervical Cages are indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one disc level. DDD is defined as discogenic pain with degeneration of the disc confirmed by patient history and radiographic studies. Fusion Advantage Cervical Cages are used to facilitate intervertebral body fusion in the cervical spine and are placed via an anterior approach at the C3 to C7 disc levels using autograft bone. Fusion Advantage Cervical Cages are to be used with supplemental fixation. Patients should have at least six (6) weeks of non-operative treatment prior to treatment with an intervertebral cage. The Fusion Advantage Lumbar Cage is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. Degenerative disc disease is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). Fusion Advantage Lumbar Cage implants are to be used with autogenous bone graft and implanted via an open posterior, transforaminal or an lateral approach. The Fusion Advantage Lumbar Cages are to be used with supplemental fixation. Patients should have at least (6) months of non-operative treatment prior to treatment with an intervertebral cage. Patients with previous non- fusion spinal surgery at involved level may be treated with the device.

Source page: https://510kreport.com/device/K083425
Methodology: https://510kreport.com/methodology